PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
+19.03%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$1.24B
AUM Growth
+$1.24B
(+17%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
10.76%
Top 10 Holdings %
Top 10 Hldgs %
56.62%
Holding
34
New
9
Increased
17
Reduced
3
Closed
5
Top Buys
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$61.5M |
| 2 |
Nuvalent
NUVL
|
$47.3M |
| 3 |
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
|
$27.2M |
| 4 |
Vir Biotechnology
VIR
|
$24.9M |
| 5 |
Immatics
IMTX
|
$22.9M |
Top Sells
| 1 |
Biogen
BIIB
|
$97.2M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$57.1M |
| 3 |
Keros Therapeutics
KROS
|
$39.7M |
| 4 |
Ascendis Pharma
ASND
|
$37.6M |
| 5 |
argenx
ARGX
|
$15.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Legend Biotech
LEGN
$6.41B
| $125M | 9.63% | 1,805,717 +295,393 | +20% | +$20.4M |
|
2
Incyte
INCY
$16.5B
| $86M | 6.65% | 1,381,711 +120,000 | +10% | +$7.47M |
|
3
Immunocore
IMCR
$1.62B
| $76.2M | 5.88% | 1,270,124 +143,868 | +13% | +$8.63M |
|
4
Arcellx
ACLX
$3.85B
| $74.2M | 5.73% | 2,347,000 +589,221 | +34% | +$18.6M |
|
|
KRTX
5
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $61.5M | 4.75% | +283,605 | New | +$61.5M |
|
|
CERE
6
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $59.4M | 4.59% | 1,868,946 +273,747 | +17% | +$8.7M |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $57.5M | 4.44% | 2,415,256 +329,558 | +16% | +$7.84M |
|
|
8
argenx
ARGX
$43.6B
| $55.4M | 4.28% | 142,259 -38,913 | -21% | -$15.2M |
|
9
United Therapeutics
UTHR
$13.8B
| $52.6M | 4.07% | 238,388 +26,496 | +13% | +$5.85M |
|
|
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $52.2M | 4.03% | 1,443,762 +46,983 | +3% | +$1.7M |
|
11
Syndax Pharmaceuticals
SNDX
$1.41B
| $50.7M | 3.92% | 2,424,132 +149,620 | +7% | +$3.13M |
|
|
BCYC
12
Bicycle Therapeutics
BCYC
$511M
| $50.7M | 3.92% | 1,985,430 +168,649 | +9% | +$4.3M |
|
|
13
Nuvalent
NUVL
$5.52B
| $47.3M | 3.65% | +1,120,465 | New | +$47.3M |
|
|
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $38.5M | 2.98% | 216,093 +32,081 | +17% | +$5.72M |
|
15
Xenon Pharmaceuticals
XENE
$2.98B
| $38.1M | 2.94% | 989,327 +338,259 | +52% | +$13M |
|
16
Olema Pharmaceuticals
OLMA
$375M
| $33.7M | 2.6% | 3,731,046 +1,348,669 | +57% | +$12.2M |
|
|
AMAM
17
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $27.2M | 2.1% | +1,650,499 | New | +$27.2M |
|
18
Crinetics Pharmaceuticals
CRNX
$2.92B
| $25.1M | 1.94% | 1,395,002 +261,220 | +23% | +$4.71M |
|
|
ALPN
19
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $24.9M | 1.93% | 2,423,961 +106,327 | +5% | +$1.09M |
|
|
20
Vir Biotechnology
VIR
$686M
| $24.9M | 1.92% | +1,014,239 | New | +$24.9M |
|
21
Zai Lab
ZLAB
$3.68B
| $24M | 1.85% | 865,297 +84,739 | +11% | +$2.35M |
|
|
22
Immatics
IMTX
$619M
| $22.9M | 1.77% | +1,984,813 | New | +$22.9M |
|
|
AUTL
23
Autolus Therapeutics
AUTL
$399M
| $21.9M | 1.7% | +9,217,150 | New | +$21.9M |
|
24
Vor Biopharma
VOR
$250M
| $20M | 1.54% | 6,461,467 -16,532 | -0.3% | -$51.1K |
|
25
Madrigal Pharmaceuticals
MDGL
$9.76B
| $19.6M | 1.52% | +85,000 | New | +$19.6M |
|